Eli Lilly releases single-dose vials of Zepbound at half the price of other obesity meds

Eli Lilly will begin selling single-dose vials of its drug tirzepatide, marketed as Zepbound for weight loss, and price them at least 50% lower than …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

ACIP Makes Changes to Adult RSV Vaccine Recommendations

All adults ages 75 years and older should receive a single dose of any respiratory syncytial virus (RSV) vaccine, and adults ages 60 to 74

June 27, 2024

Fit to beat diabetes: mendelian randomization study confirms the power of exercise

Researchers investigated the causality of the relationship between cardiorespiratory fitness and diabetes mellitus type 2.

July 5, 2023

SPY ETF will fall with interest rates heading higher, and here is my take on SPY ETF

May 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.